Epithelial-to-mesenchymal transition and estrogen receptor α mediated epithelial dedifferentiation mark the development of benign prostatic hyperplasia

Prostate

Volumn 74, Issue 9, 2014, Pages 970-982

  Shao, Rui ^a   Shi, Jiandang ^a   Liu, Haitao ^b   Shi, Xiaoyu ^a   Du, Xiaoling ^a   Klocker, Helmut ^c   Lee, Chung ^d   Zhu, Yan ^e   Zhang, Ju ^a  

^a NANKAI UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d NORTHWESTERN UNIVERSITY   (United States)

^e TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

benign prostatic hyperplasia; embryonic myosin; epithelial mesenchymal transition; estrogen receptor

Indexed keywords

CYTOKERATIN 14; CYTOKERATIN 18; CYTOKERATIN 19; CYTOKERATIN 8; ESTRADIOL BENZOATE; ESTROGEN RECEPTOR ALPHA; RALOXIFENE; TESTOSTERONE PROPIONATE; UVOMORULIN; VIMENTIN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEDIFFERENTIATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM BASAL CELL; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICRODISSECTION; MORPHOLOGICAL TRAIT; MULTIPLE CYCLE TREATMENT; NONHUMAN; PRIORITY JOURNAL; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; RAT; RECEPTOR UPREGULATION; TREATMENT RESPONSE;

BENIGN PROSTATIC HYPERPLASIA; EMBRYONIC MYOSIN; EPITHELIAL-MESENCHYMAL TRANSITION; ESTROGEN RECEPTOR Α;

AGED; ANIMALS; BLOTTING, WESTERN; CELL DEDIFFERENTIATION; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; ESTROGEN RECEPTOR ALPHA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSTATIC HYPERPLASIA; RANDOM ALLOCATION; RATS; RATS, WISTAR; RNA;

EID: 84901191342     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22814     Document Type: Article

References (34)

1. Schauer IG, Rowley DR,. The functional role of reactive stroma in benign prostatic hyperplasia. Differentiation 2011; 82 (4-5): 200-210.
2. Isaacs JT, Coffey DS,. Etiology and disease process of benign prostatic hyperplasia. Prostate Suppl 1989; 2: 33-50.
3. Arianayagam R, Arianayagam M, McGrath S, Rashid P,. Androgen deficiency in the aging man. Aust Fam Physician 2010; 39 (10): 752-755.
4. Aumuller G, Funke PJ, Hahn A, Hoffbauer G, Tunn U, Neumann F,. Phenotypic modulation of the canine prostate after long-term treatment with androgens and estrogens. Prostate 1982; 3 (4): 361-373.
5. Mahapokai W, Xue Y, van Garderen E, van Sluijs FJ, Mol JA, Schalken JA,. Cell kinetics and differentiation after hormonal-induced prostatic hyperplasia in the dog. Prostate 2000; 44 (1): 40-48.
6. Zhou Y, Xiao XQ, Chen LF, Yang R, Shi JD, Du XL, Klocker H, Park I, Lee C, Zhang J,. Proliferation and phenotypic changes of stromal cells in response to varying estrogen/androgen levels in castrated rats. Asian J Androl 2009; 11 (4): 451-459.
7. Yang R, Ma YX, Chen LF, Zhou Y, Yang ZP, Zhu Y, Du XL, Shi JD, Ma HS, Zhang J,. Antagonism of estrogen-mediated cell proliferation by raloxifene in prevention of ageing-related prostatic hyperplasia. Asian J Androl 2010; 12 (5): 735-743.
8. Ellem SJ, Risbridger GP,. The dual, opposing roles of estrogen in the prostate. Ann N Y Acad Sci 2009; 1155: 174-186.
9. Royuela M, de Miguel MP, Bethencourt FR, Sanchez-Chapado M, Fraile B, Arenas MI, Paniagua R,. Estrogen receptors alpha and beta in the normal, hyperplastic and carcinomatous human prostate. J Endocrinol 2001; 168 (3): 447-454.
10. Nicholson TM, Sehgal PD, Drew SA, Huang W, Ricke WA,. Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartment. Differentiation 2013; 85 (4-5): 140-149.
11. Chen M, Yeh CR, Chang HC, Vitkus S, Wen XQ, Bhowmick NA, Wolfe A, Yeh S,. Loss of epithelial oestrogen receptor alpha inhibits oestrogen-stimulated prostate proliferation and squamous metaplasia via in vivo tissue selective knockout models. J Pathol 2012; 226 (1): 17-27.
12. Risbridger G, Wang H, Young P, Kurita T, Wang YZ, Lubahn D, Gustafsson JA, Cunha G,. Evidence that epithelial and mesenchymal estrogen receptor-alpha mediates effects of estrogen on prostatic epithelium. Dev Biol 2001; 229 (2): 432-442.
13. Zhang J, Hess MW, Thurnher M, Hobisch A, Radmayr C, Cronauer MV, Hittmair A, Culig Z, Bartsch G, Klocker H,. Human prostatic smooth muscle cells in culture: Estradiol enhances expression of smooth muscle cell-specific markers. Prostate 1997; 30 (2): 117-129.
14. Zhang Z, Duan L, Du X, Ma H, Park I, Lee C, Zhang J, Shi J,. The proliferative effect of estradiol on human prostate stromal cells is mediated through activation of ERK. Prostate 2008; 68 (5): 508-516.
15. Zhang Z, Wang L, Mei M, Zhu Y, Du X, Lee C, Park I, Zhang J, Shi J,. Both nongenomic and genomic effects are involved in estradiol's enhancing the phenotype of smooth muscle cells in cultured prostate stromal cells. Prostate 2010; 70 (3): 317-332.
16. Kalluri R, Weinberg RA,. The basics of epithelial-mesenchymal transition. J Clin Invest 2009; 119 (6): 1420-1428.
17. Yang J, Weinberg RA,. Epithelial-mesenchymal transition: At the crossroads of development and tumor metastasis. Dev Cell 2008; 14 (6): 818-829.
18. Lee JM, Dedhar S, Kalluri R, Thompson EW,. The epithelial-mesenchymal transition: New insights in signaling, development, and disease. J Cell Biol 2006; 172 (7): 973-981.
19. Acloque H, Adams MS, Fishwick K, Bronner-Fraser M, Nieto MA,. Epithelial-mesenchymal transitions: The importance of changing cell state in development and disease. J Clin Invest 2009; 119 (6): 1438-1449.
20. Wang X, Kruithof-de Julio M, Economides KD, Walker D, Yu H, Halili MV, Hu YP, Price SM, Abate-Shen C, Shen MM,. A luminal epithelial stem cell that is a cell of origin for prostate cancer. Nature 2009; 461 (7263): 495-500.
21. Liu J, Pascal LE, Isharwal S, Metzger D, Ramos Garcia R, Pilch J, Kasper S, Williams K, Basse PH, Nelson JB, Chambon P, Wang Z,. Regenerated luminal epithelial cells are derived from preexisting luminal epithelial cells in adult mouse prostate. Mol Endocrinol 2011; 25 (11): 1849-1857.
22. Guarino M, Tosoni A, Nebuloni M,. Direct contribution of epithelium to organ fibrosis: Epithelial-mesenchymal transition. Hum Pathol 2009; 40 (10): 1365-1376.
23. Kriz W, Kaissling B, Le Hir M,. Epithelial-mesenchymal transition (EMT) in kidney fibrosis: Fact or fantasy ? J Clin Invest 2011; 121 (2): 468-474.
24. Kovacic JC, Mercader N, Torres M, Boehm M, Fuster V,. Epithelial-to-mesenchymal and endothelial-to-mesenchymal transition: From cardiovascular development to disease. Circulation 2012; 125 (14): 1795-1808.
25. Alonso-Magdalena P, Brossner C, Reiner A, Cheng G, Sugiyama N, Warner M, Gustafsson JA,. A role for epithelial-mesenchymal transition in the etiology of benign prostatic hyperplasia. Proc Natl Acad Sci U S A 2009; 106 (8): 2859-2863.
26. Rock JR, Barkauskas CE, Cronce MJ, Xue Y, Harris JR, Liang J, Noble PW, Hogan BL,. Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition. Proc Natl Acad Sci U S A 2011; 108 (52): E1475-E1483.
27. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J, Weinberg RA,. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133 (4): 704-715.
28. Scheel C, Eaton EN, Li SH, Chaffer CL, Reinhardt F, Kah KJ, Bell G, Guo W, Rubin J, Richardson AL, Weinberg RA,. Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell 2011; 145 (6): 926-940.
29. Sun Y, Wang BE, Leong KG, Yue P, Li L, Jhunjhunwala S, Chen D, Seo K, Modrusan Z, Gao WQ, Settleman J, Johnson L,. Androgen deprivation causes epithelial-mesenchymal transition in the prostate: Implications for androgen-deprivation therapy. Cancer Res 2012; 72 (2): 527-536.
30. Kuro-o M, Nagai R, Nakahara K, Katoh H, Tsai RC, Tsuchimochi H, Yazaki Y, Ohkubo A, Takaku F,. cDNA cloning of a myosin heavy chain isoform in embryonic smooth muscle and its expression during vascular development and in arteriosclerosis. J Biol Chem 1991; 266 (6): 3768-3773.
31. Polyak K, Weinberg RA,. Transitions between epithelial and mesenchymal states: Acquisition of malignant and stem cell traits. Nat Rev Cancer 2009; 9 (4): 265-273.
32. Mak P, Leav I, Pursell B, Bae D, Yang X, Taglienti CA, Gouvin LM, Sharma VM, Mercurio AM,. ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: Implications for Gleason grading. Cancer Cell 2010; 17 (4): 319-332.
33. Yu L, Wang CY, Shi J, Miao L, Du X, Mayer D, Zhang J,. Estrogens promote invasion of prostate cancer cells in a paracrine manner through up-regulation of matrix metalloproteinase 2 in prostatic stromal cells. Endocrinology 2011; 152 (3): 773-781.
34. Yu L, Shi J, Cheng S, Zhu Y, Zhao X, Yang K, Du X, Klocker H, Yang X, Zhang J,. Estrogen promotes prostate cancer cell migration via paracrine release of ENO1 from stromal cells. Mol Endocrinol 2012; 26 (9): 1521-1530.